Skip to main content

Table 1 Demographics and medical co-morbidities of bladder cancer patients undergoing cystectomy with only statistically significant p-values shown

From: Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) use

 

All patients

p-value

Diabetic subgroups

p-value

 

Non diabetic

Diabetic

 

Pioglitazone non-users

Pioglitazone users

 

N

171

33

 

24

9

 

Age (years ± SEM)

67.7

67.2

 

66.6 ± 1.5

68.7 ± 1.8

 

Sex (male)

68.4%

88%

0.009a

88%

100%

 

Race/ethnicity: No. (%)

    White

157 (91.8)

31 (94)

 

22 (92)

9 (100)

 

    Black

13 (7.6)

1 (3)

 

1 (4)

-

 

    Asian

1 (0.6)

-

 

-

-

 

    Hispanic

-

1 (3)

 

1 (4)

-

 

Smoking

71 (41.5)

12 (36.4)

 

5 (20.8)

7 (77.8)

0.012a

CV disease

46 (26.9)

19 (57.6)

0.01a

13 (54.2)

6 (66.7)

 

Pulmonary disease

26 (15.2)

7 (21.2)

 

5 (20.8)

6 (66.7)

 

Creatinine (mg/dL)

1.17

1.21

 

1.2 ± 0.07

1.23 ± 0.11

 

BMI

26.3

29.31

0.005a

29.2 ± 1.24

29.5 ± 2.3

 
  1. astudent t-test.